This disclosure relates generally to devices and methods for stimulating nerve cell regeneration and more particularly to devices and methods for stimulating nerve cell regeneration in the central nervous system of mammals through the application of oscillating DC electrical fields.
Injury to the spinal cord or central nervous system can be one of the most devastating and disabling injuries possible. Depending upon the severity of the injury, paralysis of varying degrees can result. Paraplegia and quadriplegia often result from severe injury to the spinal cord. The resulting effect on the sufferer, be it man or animal, is severe. The sufferer can be reduced to a state of near immobility or worse. For humans, the mental trauma induced by such severe physical disability can be even more devastating than the physical disability itself.
When the spinal cord of a mammal is injured, connections between nerves in the spinal cord are broken. The injured portion of the spinal cord is termed a “lesion.” Such lesions block the flow of nerve impulses for the nerve tracts affected by the lesion with resulting impairment to both sensory and motor function.
To restore the lost sensory and motor functions, the affected motor and sensory axons of the injured nerves must regenerate, that is, grow back. Unfortunately, any spontaneous regeneration of injured nerves in the central nervous system of mammals has been found to occur, if at all, only within a very short period immediately after the injury occurs. After this short period expires, such nerves have not been found to regenerate further spontaneously.
Studies have shown, however, that the application of a DC electrical field across a lesion and the damaged nerve ending adjacent the lesion in the spinal cord of mammals, can promote axon growth, and the axons will grow back around the lesion. Since the spinal cord is rarely severed completely when injured, the axons need not actually grow across the lesion but can circumnavigate the lesion through remaining spinal cord parenchyma.
Although axon growth can be promoted by the application of a steady DC electrical field, only those axons facing the cathode (negative pole) are stimulated to grow. Axons facing the anode (positive pole) not only are not stimulated to grow, but actually reabsorb into the bodies of the nerve cells (“die back),” after a period of time. In order to “repair” an injured spinal cord, regeneration of both the ascending and descending nerve tracks must be promoted. Thus, axons growth in both directions, i.e., rostrally and caudally, must be stimulated to “repair” an injured spinal cord.
For optimal results in a human patient, a uniform electrical field of a desired strength is imposed over about 10 cm to 20 cm of damaged spinal cord for a beneficial clinical outcome. Ideally, this uniform field is imposed across the entire cross section of the spinal cord over this longitudinal extent, because of the general segregation of descending (motor) tracts to the ventral (anterior) cord, and the segregation of important (largely sensory) tracts to the posterior (dorsal) spinal cord. In paraplegic canines, this electrical field has been directly measured (Richard B. Borgens, James P. Toombs, Andrew R. Blight, Michael E. McGinnis, Michael S. Bauer, William R. Widmer, and James R. Cook Jr., Effects of Applied Electric Fields on Clinical Cases of Complete Paraplegia in Dogs, J. Restorative Neurology and Neurosci., 1993, pp. 5:305-322). In man however, the cross sectional area of the spinal cord is approximately two to four times that of the small to medium sized dogs treated in clinical trials, and actual invasive measurement of the imposed electrical fields is not feasible on human patients.
Based on the responses of human paraplegics and quadriplegics to prior art therapies involving the application of an oscillating DC electrical field across a lesion in the spinal cord using three pairs of electrodes, it appears that the dorsal (posterior) location of three pairs of electrodes did not produce a uniform field over the entire unit area of the patient's spinal cord. This was revealed by the domination of sensory recovery in these patients (greater than thirty fold over historical controls) compared to motor recovery (approximately twofold greater than historical controls) using the ASIA scoring system. Thus, this result indicates that when the prior treatment method is utilized the voltage gradient was highest nearest to the actual location of electrode placement. In the prior method of treatment two pairs of electrodes were placed on either side (two tethered to the right and left lateral facets) and a third pair was sutured to the paravertebral muscle and fascia of the dorsal (posterior) facet rostrally and caudally of the spinal cord lesion (Shapiro, et al., Oscillating Field Stimulation for Complete Spinal Cord Injury in Humans: a Phase 1 Trial, Journal of Neurosurg. Spine 2, 2005, pp. 3-10).
It would be desirable to provide a device to generate a stronger DC electrical field across the spinal cord lesion and the areas adjacent thereto (over the entire cross-sectional area of the spinal cord and the intact areas bordering the lesion rostrally and caudally) of a human in order to facilitate the creation of a uniform electrical field over the entire affected area. It would be further desirable to provide a method for implanting electrodes that facilitates the creation of a uniform electrical field over the affected area of the injured spinal cord.
Existing devices to generate a DC electrical field across a lesion and areas adjacent thereto in the spinal cord of mammals are implanted into the patient, and powered by a battery. These batteries are sealed and are not readily rechargeable. Therefore, when a patient could benefit from longer terms of treatment, either a larger battery must be used, or the device must be removed from the patient and replaced via a surgery. It would be desirable to provide a device to generate the DC electrical field across the spinal cord lesion and the areas adjacent thereto that has a smaller battery, a battery with a longer useful life, or both.
The devices of the existing technology are shielded from the biology with Teflon. Over time, Teflon may allow seepage of bodily fluids into the device, which would in turn lead to chemical compounds from the device being absorbed by the surrounding tissue. It would be desirable to provide a case for a device that acts as a persistent barrier between the circuitry of the device and the surrounding tissue.
According to one aspect of the disclosure, an apparatus for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises a constant current DC stimulus generator, first and second groups of electrodes, a beacon signal generator and a polarity reversing circuit. The constant current DC stimulus generator has first and second groups of oppositely polarized output terminals. The one of the first or second groups of output terminals comprises a cathode and the other one of the first or second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. The beacon signal generator is electrically coupled to the DC stimulus generator. The polarity reversing circuit is electrically coupled to the constant current DC stimulus generator and is configured to reverse the polarity of the DC stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal.
According to another aspect of the disclosure, an apparatus for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises a stimulus generator, first and second electrodes and a polarity reversing circuit. The stimulus generator is capable of generating a chopped DC current and has first and second oppositely polarized output terminals. The one of the first or second output terminals comprises a cathode and the other one of the first or second output terminals comprises an anode of the generator. The first and second electrodes are electrically coupled respectively to the first and second output terminals. The polarity reversing circuit is electrically coupled to the stimulus generator and is configured to reverse the polarity of the stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal.
According to yet another aspect of the disclosure, a method for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises providing a device and implanting the device in a mammal. The provided device comprises a constant current DC stimulus generator, first and second groups of electrodes, a beacon signal generator and a polarity reversing circuit. The constant current DC stimulus generator has first and second groups of oppositely polarized output terminals. The one of the first or second groups of output terminals comprises a cathode and the other one of the first or second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. The beacon signal generator is electrically coupled to the DC stimulus generator. The polarity reversing circuit is electrically coupled to the constant current DC stimulus generator and is configured to reverse the polarity of the DC stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal.
According to yet another aspect of the disclosure, a method for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises providing a device and implanting the device in a mammal. The provided device comprises a stimulus generator, first and second groups of electrodes and a polarity reversing circuit. The stimulus generator is capable of generating a chopped DC current and has first and second groups of oppositely polarized output terminals. The one of the first or second groups of output terminals comprises a cathode and the other one of the first or second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. The polarity reversing circuit is electrically coupled to the stimulus generator and is configured to reverse the polarity of the stimulus each time a predetermined period of time elapses. Each time the polarity of the stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal.
According to another aspect of the disclosure, an apparatus for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises a constant current DC stimulus generator, first and second groups of electrodes, a rechargeable charge storage device, and a polarity reversing circuit. The constant current DC stimulus generator has first and second groups of oppositely polarized output terminals. One of the first or second groups of output terminals comprises a cathode and the other one of the first or second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. The rechargeable charge storage device is electrically coupled to the constant current DC stimulus generator. The polarity reversing circuit is electrically coupled to the constant current DC stimulus generator and is configured to reverse the polarity of the DC stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal.
According to another aspect of the disclosure, an apparatus for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises a constant current DC stimulus generator, first and second groups of electrodes, a charge storage device, a case and a polarity reversing circuit. The constant current DC stimulus generator has first and second groups of oppositely polarized output terminals. One of the first or second groups of output terminals comprises a cathode and the other one of the first or second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. The charge storage device is electrically coupled to the constant current DC stimulus generator. The case has a top portion and a bottom portion. The constant current DC stimulus generator and the charge storage device are positioned between the top portion and bottom portion. The polarity reversing circuit is electrically coupled to the constant current DC stimulus generator and is configured to reverse the polarity of the DC stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the to polarity reversal comprises the cathode after the polarity reversal.
According to yet another aspect of the disclosure, an apparatus implanted in a mammalian body having a spine and a lesion in the spinal cord for stimulating axon growth of the nerve cells in the spinal cord of mammals comprises a constant current DC stimulus generator, First and second groups of electrodes, and a polarity revering circuit. The constant current DC stimulus generator has first and second groups of oppositely polarized output terminals wherein one of the first and second groups of output terminals comprises a cathode and the other of the first and second groups of output terminals comprises an anode of the generator. The first and second groups of electrodes are electrically coupled respectively to the first and second groups of output terminals. Each of said first and second groups of electrodes having a first electrode corresponding to a first electrode of the other of the first and second groups, a second electrode corresponding to a second electrode of the other of the first and second groups, a third electrode corresponding to a third electrode of the other of the first and second groups, and a fourth electrode corresponding to a fourth electrode of the other of the first and second groups. The polarity reversing circuit is electrically coupled to the constant current DC stimulus generator and is configured to reverse the polarity of the DC stimulus each time a predetermined period of time elapses. Each time the polarity of the DC stimulus is reversed the output terminal which comprised the cathode before the polarity reversal comprises the anode after the reversal and the output terminal which comprised the anode before the polarity reversal comprises the cathode after the polarity reversal. The first electrodes of the first and second group of electrodes are positioned on the right lateral facet of the spine of the mammalian body with the electrode of the first group of electrodes positioned rostrally from the lesion and the electrode of the second group of electrodes positioned caudally from the lesion. The second electrodes of the first and second group of electrodes are positioned on the left lateral facet of the spine of the mammalian body with the electrode of the first group of electrodes positioned rostrally from the lesion and the electrode of the second group of electrodes positioned caudally from the lesion, the third electrodes of the first and second group of electrodes are positioned on the paravertebral muscle and fascia of the dorsal (posterior) facet of the mammalian body with the electrode of the first group of electrodes positioned rostrally from the lesion and the electrode of the second group of electrodes positioned caudally from the lesion, and the fourth electrodes of the first and second group of electrodes are positioned adjacent to paravertebral musculature at the extreme mediolateral/ventral (anterior) vertebral column of the mammalian body with the electrode of the first group of electrodes positioned rostrally from the lesion and the electrode of the second group of electrodes positioned caudally from the lesion.
Additional features and advantages will become apparent to those skilled in the art upon consideration of the following detailed description of a preferred embodiment exemplifying the best mode of carrying out the invention as presently perceived.
The features and advantages of the disclosed devices, and the methods of obtaining them, will be more apparent and better understood by reference to the following descriptions of embodiments of the devices, taken in conjunction with the accompanying drawings, wherein:
For the purposes of promoting an understanding of the principles of the disclosure, reference will now be made to the embodiments illustrated in the drawings and described in the following written specification. It is understood that no limitation to the scope of the disclosure is thereby intended. It is further understood that the present invention includes any alterations and modifications to the illustrated embodiments and includes further applications of the principles of the disclosure as would normally occur to one skilled in the art to which this invention pertains.
The application of an oscillating DC electrical field across a lesion and the area adjacent the lesion in the spinal cord of a mammal can stimulate axon growth in both directions, i.e., caudally and rostrally. That is, growth of caudally facing axons will be promoted as will growth of rostrally facing axons. The DC electrical field is a constant current stimulus which is first applied in one direction for a predetermined period of time and then applied in the opposite direction for the predetermined period of time. The polarity of the constant current DC stimulus is reversed after each predetermined period of time.
In
In accordance with the present disclosure, the nerves in the central nervous system of a mammal are stimulated to regenerate by applying an oscillating electrical field to the central nervous system. The oscillating electrical field is a constant current DC stimulus which is first applied in one direction for a predetermined period of time, and then applied in the opposite direction for the predetermined period of time. In other words, the polarity of the constant current DC stimulus is reversed after each predetermined period of time. The predetermined period of time is selected to be less than the die back period of anodal facing axons, but long enough to stimulate growth of cathodal facing axons. This predetermined period will be termed the “polarity reversal period” of the oscillating electrical field. In one disclosed embodiment, this polarity reversal period is between about thirty seconds and about sixty minutes.
Circuit 300 includes a power supply and supervisory section 304, and a secondary watchdog section 306. The power supply and supervisory section 304 produces a 3.6 volt supply for powering the remaining devices of circuit 300, including secondary watchdog section 306 and the optional beacon circuit 320 and the main oscillator of timer 382. Additionally, the power supply and supervisory section 306 supervises the oscillator circuitry of the timer 382 to determine if there is failure of the oscillator circuit.
The power supply and supervisory circuit 304 includes a battery 302, processor supervisor circuit 352, a resistor 301, a first capacitor 303, a second capacitor 305, a switch 307, a first transistor 308, and a second transistor 309 configured as shown in
In one illustrated embodiment, the switch 307 may be an HSR-502RT reed switch available from Hermetic Switch, Inc., Chickasha, Okla. However, other switches may be used within the scope of the disclosure. The HSR-502 reed switch is a single pole-double throw (SPDT) switch enclosed in a glass capsule.
In one illustrated embodiment, transistors 308 and 309 may be BSS138 transistors available from Fairchild Semiconductor Corporation, South Portland, Me., although other transistors and appropriate components can be used within the scope of the disclosure. In one illustrated embodiment, the transistors 308, 309 are N-Channel Logic Level Enhancement Mode Field Effect Transistors. The values of the resistor 301 and capacitors 303, 305 are chosen as required to meet design parameters. In the illustrated embodiment, resistor 301 is a 1 Mohm resistor and capacitors 303, 305 are 0.047 microfarad capacitors.
The processor supervisor circuit 352 receives a clock pulse signal from the oscillator section of timer 382. In one illustrated embodiment, the processor supervisor circuit 352 is a TPS 3823 Processor supervisor circuit with watchdog timer input (W) and Manual Reset Input (/MR) available from Texas Instruments, Dallas Tex. The illustrated processor supervisor circuit 352 includes a Power-On Reset Generator With Fixed Delay Time of 200 ms. The illustrated processor supervisor circuit 352 provides circuit initialization and timing supervision for the timer 382. During power-on, /RESET (/RS) is asserted when supply voltage (V+) becomes higher than 1.1 V. Thereafter, the supply voltage supervisor monitors the supply voltage and keeps /RESET active as long as the supply voltage remains below the threshold voltage. An internal timer delays the return of the output to the inactive state (high) to ensure proper system reset. The delay time, td, starts after supply voltage has risen above the threshold voltage. When the supply voltage drops below the threshold voltage, the output becomes active (low) again. The illustrated processor supervisory circuit 352 has a fixed-sense threshold voltage set by an internal voltage divider. The illustrated processor supervisor circuit 352 incorporates a manual reset input, (/MR). A low level at the manual reset input (/MR) causes /RESET to become active. The illustrated processor supervisor circuit 352 includes a high-level output at /RESET (/RS).
The arrangement illustrated in
The secondary watchdog section 306 includes adjustable current supply 354, switch 380, op amp 396, resistors 312-315 and capacitors 321. While the illustrated secondary watchdog section 306 is configured in accordance with the schematic shown in
In one illustrated embodiment, op amp 386 is an Analog Devices OP90GS Precision, Low Voltage Micropower Operational Amplifier, available from One Technology Way, Norwood, Mass. Other operational amplifiers or amplifier circuitry may be utilized within the scope of the disclosure.
In one illustrated embodiment, the switch 380 is a MAX4544CSA Low-Voltage, Single-Supply Dual SPDT Analog Switch available from Maxim Integrated Products, Sunnyvale, Calif. The MAX4544 is a dual analog switch designed to operate from a single voltage supply, which because of its low power consumption (5 μW) is particularly well adapted for battery-powered equipment. The disclosed switch 380 offers low leakage currents (100 pA max) and fast switching speeds (tON=150 ns max, tOFF=100 ns max). The MAX4544 switch 380 is a single pole/double-throw (SPDT) device.
In one illustrated embodiment, the timer 382 is a CD4060B type CMOS 14-stage ripple-carry binary counter/divider and oscillator, available from Texas Instruments, Dallas, Tex. The illustrated CD4060B timer 382 consists of an oscillator section and 14 ripple-carry binary counter stages. A RESET input is provided which resets the counter to the all-O's state and disables the oscillator. A high level on the RESET line accomplishes the reset function. All counter stages are master-slave flip-flops. The state of the counter is advanced one step in binary order on the negative transition of PI (and PO). All inputs and outputs are fully buffered. Schmitt trigger action on the input-pulse line permits unlimited input-pulse rise and fall times.
In the illustrated embodiment, the watchdog timer input to the processor supervisor circuit 352 is coupled to the PO output of the timer 382 to provide a pulsed clock signal to indicate proper operation of the timer 382 which controls the polarity reversal period. Absence of this signal causes the supervisor circuit 352 to shut down power to the entire system. The /PO pin of the timer 382 is coupled through resistors 316 and 317 to the PI pin of the timer 382. The positive electrode of capacitor 323 is coupled to a node coupling the terminals of resistors 316 and 317, while the negative electrode of the capacitor 323 is coupled to a node coupled to the PO pin of the timer 382 thereby forming a free running oscillator. The period of the free-running oscillator is determined by the values of the resistors 316 and 317 and the capacitor 323. In the illustrated embodiment, the resistors 316 and 317 each have a resistance of 1 Mohm and the capacitor has a 0.047 micro-farad capacitance so that the oscillator runs at a frequency to generate the desired reversal period. The values of the resistors 316 and 317 and capacitor 323 can be varied to obtain reversal periods of different values within the scope of the disclosure.
The Q7 pin of the counter of the timer is coupled to node 327 to provide a pulse to activate the optional beacon circuit 320. The Q14 pin of the timer 382 is coupled to a group B node 330, i.e. a node providing power to the adjustable current sources 368, 370, 372, 374, 376 and 378 driving the Group B electrodes 346, 348 and 350. The reset pin of the timer 382 is coupled to a node that is coupled through the capacitor 322 to the positive voltage terminal 311 and coupled through resistor 318 to a node coupled to both the ground terminal 310 and the ground pin of the timer 382. The power supply pin of the timer 382 is coupled to the positive voltage terminal 311.
The adjustable current source 354 of the secondary watchdog section 306 has its positive supply pin (V+) coupled to a node coupled to the positive voltage terminal 311. This adjustable current source 354 provides a reference current that is utilized by op amp 396 to generate a signal to turn off the output power when the voltage drops below a specified value (illustratively 2.8V). In the illustrated embodiment, the adjustable current source 354 was selected to generate a second reference voltage instead of selecting a zenor diode to avoid the power loss associated with zenor diodes when utilized as reference voltage generators. The output power is interrupted in the illustrated circuit 300 by adjustable current source 354 and op amp 396 cooperating to lift the ground of switch 380 to interrupt current outflow to the group A electrodes.
The negative pin (V−) of the adjustable current source 354 is coupled to the central node of a first voltage divider formed by resistors 312 and 313. The central node of the first voltage divider is coupled through the resistor 313 to the ground terminal 310 and is also coupled through a node to the non-inverting input of op amp 396. The capacitor 321 is in parallel with the resistor 313 between the central node of the first voltage divider and the ground terminal 310. The resistors 314 and 315 form a second voltage divider having a central node coupled to the inverting input of the op amp 396. The second voltage divider is coupled between the positive voltage terminal 311 and the ground terminal 310. The positive voltage terminal 311 is also coupled to the voltage supply pin of the op amp 396 and the ground terminal 310 is coupled to the ground pin of the op amp 396. The output of the op amp is coupled to the Ground-Negative Supply Input pin of the switch 380.
The Positive Supply Voltage Input pin of the switch 380 is coupled to the positive voltage terminal 310. The Ground-Negative Supply Input pin of the switch 380 is coupled to the output of the op amp 396. The Normally Open pin of the switch 380 is coupled to the ground terminal 310. The Common pin of the switch 380 is coupled to the Group A node, i.e. the node for providing the power to the adjustable current supplies 356, 358, 360, 362, 364 and 366 powering the Group A electrodes 340, 342, 344. The Normally Closed pin of the switch 380 is coupled to the positive voltage terminal 311. The Digital Control Input pin of the switch 380 is coupled to the Group B node which, as mentioned above, is also coupled to the Q14 pin of the timer 382. Thus, the timer 382 is configured to cause the Group A electrodes and Group B electrodes to switch between anodes and cathodes to generate a waveform such as that shown in
Circuit 800 does differ however in some respects from circuit 300, specifically, as shown, for example, in
In this embodiment, the recharging electrodes 804 and 806 are implanted near the surface of skin of the patient. In one preferred embodiment, the recharging electrodes 804 and 806 are implanted into the dermis, either in the papillary layer, or the reticular layer. In another preferred embodiment, the recharging electrodes 804 and 806 are implanted in the epidermis, in either the stratum spinosum or stratum basale layer. Implantation of the recharging electrodes 804 and 806 in the stratum corneum is also possible, but could cause discomfort or other problems because of the near proximity of the recharging electrodes 804 and 806 to the surface.
In operation, an external charging circuit (not shown) is removably coupled to the recharging electrodes 804 and 806 prior to implantation of the circuit in the patient. Preferably, the external charging circuit is removably coupled to the recharging electrodes 804 and 806 for a sufficient period of time to fully charge the rechargeable charge storage device 802 just prior to a procedure to implant the circuit. After some period of time, six weeks for example, the rechargeable battery 802 may discharge to the point that the circuit is no longer operating at an optimum level. At this time, or any time, a simple procedure may be performed under local anesthetic to expose the recharging electrodes 804 and 806. During this procedure, the external charging circuit may be removably coupled to the recharging electrodes 804 and 806 for a period of time in order to recharge the rechargeable charge storage device 802. Once the recharging of the rechargeable charge storage device 802 is complete, the recharging electrodes 804 and 806 may be re-implanted into the patient.
In the illustrated embodiments of circuits 300, 700 and 800 each electrode 340, 342, 344, 346, 348, 350, 384 and 386 is coupled to a pair of adjustable current sources connected in parallel with opposite polarity to generate the desired bidirectional current (ISET) for the electrode. In the illustrated embodiment, electrode 340 is coupled to current sources 356 and 358, electrode 342 is coupled to current sources 360 and 362, electrode 344 is coupled to current sources 364 and 366, electrode 346 is coupled to current sources 368 and 370, electrode 348 is coupled to current sources 372 and 374 and electrode 350 is coupled to current sources 376 and 378. In the illustrated embodiment, since each current source provides current in one direction only, i.e. uni-directional current, identical mirrored current sources are connected in parallel with opposite polarity (also referred to as “back-to-back”) to provide bidirectional current to facilitate the switching of the polarity of the groups of electrodes as described herein. The bias current for each first adjustable current source is determined in part by the values of bias resistors R1-16. The arrangement of the current sources in parallel with opposite polarity facilitates bidirectional current flow through the electrodes. While illustrated as utilizing back-to-back adjustable current sources to provide the power to electrodes, it is within the scope of the disclosure for other current sources, including, but not limited to, stand alone bidirectional adjustable current sources, to be utilized to provide power to the electrodes in circuits 300, 700 and 800.
Among the current sources that can be utilized for current sources 354, 356, 358, 360, 362, 364, 366, 368, 370, 372, 374, 376, 378, 388, 390, 392 and 394 are the LM334 series of three terminal adjustable current source available from National Semiconductor. The total current through each LM334 (ISET) is the sum of the current going through the SET resistor (in the illustrated embodiment resistors R1-16) and the LM334's bias current (IBIAS). Other current sources can be utilized in circuits 300, 700 and 800 within the scope of the disclosure and calibrated to produce the desired output current to each electrode.
Referring now to
Referring now to
The switch 604 is a 74LVC1G66 Bilateral switch available from Philips Semiconductors, Eindhoven, The Netherlands.
The 74LVC1G66 is a high-speed Si-gate CMOS device. The 74LVC1G66 provides an analog switch. The switch has two input/output pins (Y and Z) and an active HIGH enable input pin (E). When pin E is LOW, the analog switch is turned off.
JFETs 606 and 608 are N-Channel Silicon Junction Field-Effect Transistor available from InterFET Corporation, Garland Tex.
In one illustrated embodiment, the counter 602, like timer 382 in circuits 300, 700 and 800, is a CD4060B type CMOS 14-stage ripple-carry binary counter/divider and oscillator, available from Texas Instruments, Dallas, Tex. With this and the prior statements regarding circuit 600 in mind, it will be seen that the pins of counter 602 are configured similarly to the pins in timer 382 in circuits 300, 700 and 800. However counter 602 is also coupled to a chopper circuit as explained below. Due to the similarity of the configuration of counter 602 in circuit 600 and timer 382 in circuits 300, 700, 800, it is easily understood how circuits 300, 700 and 800 can be modified to implement a chopper circuit.
In the illustrated embodiment, loop 630 consists of a simple loop of wire. Since circuit 600 is configured for use in small mammals, a complex beacon circuit 320, such as that shown in
The /PO pin of the counter 602 is coupled through resistors 636 and 638 to the PI pin of the counter 602. The negative electrode of capacitor 624 is coupled to a node coupling the terminals of resistors 636 and 638, while the positive electrode of the capacitor 634 is coupled to a node coupled to the PO pin of the counter 602 and the loop 630. The Q7 pin of the counter 602 in circuit 600 is shown as floating, but it is within the scope of the disclosure for the Q7 pin of the counter 602 to be coupled to node 327 to provide a pulse to activate the optional beacon circuit 320.
The Q14 pin of the counter 602 is coupled through a node coupled through resistor 640 to a group B node 646, i.e. a node providing power to the Group B electrode 610, and to the logic inputs of the NAND gate 618. The reset pin of the counter 602 is coupled to a node that is coupled through the capacitor 632 to the positive terminal of battery 624 and coupled to a node coupled to the ground pin of the counter 602 and through the switch 628 to the negative terminal of battery 626. The power supply pin of the counter 602 is coupled to the positive terminal 311 of battery 624. Batteries 626 and 624 are coupled in series.
The Q8 pin of counter 602 is coupled to the anode of diode 614, the cathode of diode 614 is coupled to one terminal of jumper 620. The other terminal of jumper 620 is coupled to a node coupled to Enable input pin of the switch 604, to one terminal of jumper 622 and through resistor 646 and switch 628 to the negative terminal of battery 626. The other terminal of jumper 622 is coupled to the cathode of diode 616 which has its anode coupled to the Q9 pin of the counter 602. The Y independent input/output pin of switch 604 is coupled to the output of the NAND gate 618. The Z independent output/input pin of switch 604 is coupled to a node that is coupled to the gate of JFET 606 and through resistor 642 to the source of JFET 606. The drain of JFET 608 is coupled to the drain of JFET 608. The source of JFET 608 is coupled through resistor 644 to a node coupled to the gate of JFET 608 and to A electrode power node 648.
In the illustrated embodiment of circuit 600, JFETs 606 and 608 and their associated resistors 642 and 644, respectively, comprise bidirectional constant current sources. JFETs 606 and 608 and their associated resistors 642 and 644 are utilized as constant current sources in circuit 600 instead of the adjustable current sources found in circuits 300, 700 and 800, because they reduce the size of circuit 600 to facilitate implantation of circuit 600 into small mammals.
The ground pin of NAND gate 618 and the ground pin of switch 604 are coupled through switch 628 to the negative terminal of battery 626. The supply voltage pin of NAND gate 618 and the supply voltage pin of switch 604 are coupled to the positive terminal of battery 624
Circuit 600 comprises a current chopping circuit. The DC current is “chopped” or turn off for a short but fixed amount of time. For example, by setting jumper 620 to a 25% duty cycle and jumper 622 to a 50% duty cycle, the DC current exhibits an on duty cycle Don 1202 of 75% (jumper 620 plus jumper 622) and off duty cycle Doff 1204 for 25% of the time, chopped once per minute producing a wave form as shown in
In one disclosed embodiment, where polarity reversal period DT 1206 of the oscillating electrical field is set to 10 minutes and the duty cycle of the current is set to 75%, circuit 600 produces an output wave form as shown in
It is within the scope of the disclosure for the on duty cycle 1202 to be between 60% and 99%. Clinically effective results may be obtained in one embodiment when the on duty cycle 1202 is between 70% and 85%. Clinically effective results may be obtained in another embodiment when the on duty cycle 1202 is between 75% and 80%.
In operation, a device comprising circuit 300, 600, 700 or 800 is implanted into an injured mammal shortly after the time of central nervous system injury. The device comprising circuit 300, 600, 700, 800 remains implanted for a period of time post-injury. For example, the device comprising circuit 300, 600, 700, 800 remains implanted for up to fourteen weeks in humans.
Power is applied to the device comprising circuit 300, 600, 700, 800 during implantation. When power is applied, the circuit generates an oscillating electrical field at Electrode Group A and Electrode Group B. That is, the circuit generates a constant current DC stimulus the polarity of which is reversed periodically after the expiration of a predetermined period of time determined by the operation of timer 382 (or counter 602 in circuit 600). Electrode Group A and Electrode Group B alternately comprise cathode and anode terminals, respectively, depending upon the polarity of the DC stimulus.
The voltage between from Electrode Group A and Electrode Group B is selected to provide sufficient field strength in the section of the spinal cord in which nerve regeneration is to be stimulated. A field strength of 200 μV/mm in the spinal cord adjacent the lesion will stimulate regeneration. The current needed to achieve this field strength is determined by the geometry of the animal in which a device comprising circuit 300, 600, 700, 800 is used and the location of the nearest electrode to the lesion. While a field strength of 200 μV/mm will stimulate regeneration, a field strength of 600 μV/mm has been found to produce clinically effective nerve regeneration.
Illustratively, electrodes 340, 342, 344, 346, 348, and 350 comprise silastic insulated platinum-iridium electrodes. Electrode Groups A and B are implanted on opposite sides of a lesion in the spinal cord. It is sufficient to implant Electrode Groups A and B in a laminectomy adjacent the spinal cord but not actually in the spinal cord. Further, moving the anode from within the laminectomy to a site on the muscle dorsal to the same area results in only about a ten percent drop in field strength as does the converse of moving the cathode to a more superficial position while leaving the anode in the laminectomy. Further, uniform field homogeneity can be achieved by locating the electrodes anywhere on the midline of the spinal cord, including locating both electrodes on the same side of the lesion but spaced apart, although locating the electrodes on opposite sides of the lesion is preferred.
Applicants have also found that the field strength within the spinal cord at the site of the lesion depends upon the location of the current delivery electrodes. The convergence of current to an electrode produces high current density and hence higher field strength near each electrode. The closer one electrode is to the lesion site, the less critical is the placement on the other to maintain high field strengths. However, as a current delivery electrode location approaches the location of the lesion, current direction becomes less uniform. At a lesion exactly half-way between two electrodes placed on the midline, the current will all be oriented along the long axis of the subject animal. As one of the electrodes is moved closer to the lesion, there will be a larger vertical (dorsal-ventrical) component of the current at the lesion (assuming that the electrodes remain a few millimeters dorsal to the target tissue).
As a compromise between uniform current direction and maximum field strength, applicants have chosen to position the electrodes two vertebral segments on either side of the lesion in their spinal cord studies. In the guinea pig studies applicants have conducted, it appears that at least one electrode should be positioned within one convergence zone of an electrode from the lesion. A convergence zone is that area in which the current convergence to the electrode so dominates the field strength that the position of the other electrode is relatively inconsequential. Utilizing the illustrated electrodes, the convergence one is approximately 1 cm. Therefore, by placing one electrode within 1 cm of the lesion, the position of the other becomes relatively inconsequential and becomes a matter of convenience. It should be noted, however, that the electrodes can be located further from the lesion. If they are, the field strength of the electrical field at the lesion for a given magnitude of current will be reduced. Therefore, the magnitude of the current would have to be increased to yield the same electrical field strength at the lesion.
For optimal results in a human patient, uniform electrical field of the desired strength is imposed over about 10 cm to 20 cm of damaged spinal cord surrounding the lesion for a beneficial clinical outcome. Ideally, this uniform field is imposed across the entire cross section of the spinal cord over this longitudinal extent, because of the general segregation of descending (motor) tracts to the ventral (anterior) cord, and the segregation of important (largely sensory) tracts to the posterior (dorsal) spinal cord. Circuit 700 is configured to facilitate provision of such a uniform field. This uniform electrical field of the desired strength may be generated by placing two pairs of electrodes, for example electrodes 340, 346, 342, and 348, on either side (two tethered to the right and left lateral facets) and a third pair, for example electrodes 344 and 350, sutured to the paravertebral muscle and fascia of the dorsal (posterior) facet rostrally and caudally of the spinal cord lesion. Additionally, a fourth pair of electrodes, for example 384 and 386, are sutured to paravertebral musculature at the extreme mediolateral/ventral (anterior) vertebral column. The placement of this fourth pair of electrodes 384 and 386 should alleviate the reduction of the voltage gradient imposed over motor columns in the anterior (ventral) spinal cord.
Once inside a patient, it is difficult to verify the operation of a device comprising circuit 300, 600, 700, 800. Visible verification is impossible while the device is within a patient. Operation of the device within the patient could be determined by attaching an electrocardiogram (EKG) system to the patient and waiting to observe a small transient on the EKG record associated with the reversal of the electrical field imposed over the spinal cord, but this is a time consuming procedure.
Optional beacon circuit 320 can be used with circuit 300, 600, 700 or 800 to enable rapid verification of device operation. Beacon circuit 320 can be any circuit that enables visible and/or audible verification of device operation. Beacon circuit 320 also can transmit data regarding device operation, such as, for example, using RF telemetry.
In an embodiment, a small LED “beacon” is inserted into circuit 300, 600, 700, and 800. A periodic visible burst of light such as, for example, every 7 seconds, reveals nominal unit operation prior to implantation. After implantation this burst of light may in certain circumstances be visible transdermally.
In an embodiment, a low-frequency oscillator connected to a small-coil antennae within the device unit enables verification of operation following device implantation. A pulsed signal is transmitted by the oscillator/antennae. A small acoustic amplifier placed near the implantation site on the patient amplifies this signal and audiblizes it as a “chirp”.
As shown, for example, in
The other electrode of resistor 412 is coupled to a node 428 to which one electrode of resistor 410, the negative electrode of capacitor 418 and the positive electrode of capacitor 416 is coupled. the other electrode of resistor is coupled to the base of the transistor 404 and to one electrode of resistor 408. The other electrode of resistor 408 is coupled to node 325. Resistors 408 and 410 are coupled and configured to define a voltage divider dividing the voltage between node 325 and node 428. The positive electrode of capacitor 418 is coupled to node 325. The negative electrode of capacitor 416 is coupled to node 327 which is coupled to the Q7 pin of the timer 382 (
When configured as shown in
Various commercially available electronic components may be utilized to implement receiver circuit 500. In one embodiment of receiver circuit 500, function generator 502 is an XR2206 Monolithic Function Generator available from Exar Corporation, Fremont Calif.
In one embodiment of receiver circuit 500, modulator/demodulator 504 is an MC1496 Balanced Modulators/Demodulators available from ON Semiconductor, Denver, Colo. Other modulator/demodulators may be use in circuit 500 within the scope of the disclosure. The modulator/demodulator 504 is designed for use where the output voltage is a product of an input voltage (signal) and a switching function (carrier) generated by the function generator 502.
In one embodiment of receiver circuit 500, amplifier 506 is an LM386 Low Voltage Audio Power Amplifier available from National Semiconductor Corporation, Santa Clara, Calif.
In one embodiment of receiver circuit 500, pickup coil 508 is formed by coiling 200 turns of #34 wire into a 2.5 inch diameter coil on a four foot coaxial cable.
In one embodiment of receiver circuit 500, transistors are 2N3904 NPN General Purpose Amplifier transistors, from Fairchild Semiconductor Corporation, South Portland, Me.
In one embodiment of receiver circuit 500, batteries 516 and 518 are 9 volt batteries.
In operation, external portion 1010 operates as an electric or magnetic field generator 1012. The field may also be alternating current or radio frequency, in which case it will be coupled wirelessly, by means of inductive or capacitive coupling to the field receiver 1024. The field receiver 1024 may be two conductive leads that receive charge from the field generator 1012. Alternatively, field receiver 1024 may be a conductive coil onto which a magnetic field will be coupled from the field generator 1012. Alternatively, field receiver 1024 may be a capacitive plate onto which an electric field will be coupled from the field generator 1012.
The field-to-current converter 1026, may operate to transform magnetically or electrically coupled fields to direct current fields through charge-rectifying and/or signal conditioning. The field-to-current converter 1026 may also regulate coupled power delivery for appropriate charging of the charge storage device 1022. Simultaneously, during charging, the field-to-current converter 1026 can also supply power to the nodes 808 and 810 of the circuit 300, in addition to the charge-storage device 1022.
The charge storage device 1022 may be a rechargeable battery, such as the rechargeable battery 802, or a capacitor. The charge storage device 1022 may store power received from the field-to-current converter 1022 up to its maximum capacity, which is monitored by the field-to-current converter 1022 to avoid over-charging of the charge storage device 1022. Upon reaching maximum capacity, the charge storage device 1022 may contain enough power to power the circuit 300 via the nodes 808 and 810 for the appropriate length of time, and charging may cease.
The circuit 300, 600, 700, 800 which may comprise one or more circuit boards, may be coupled to the case 1100. The circuit 300 is shown coupled to the bottom portion 1102 of the case 1100 in
One or more orifices 1108 and 1110 in on or more walls of the case 1100 may allow a first plurality of electrodes, such as electrodes 340, 342 and 344, and a second plurality of electrodes, such as electrodes 346, 348 and 350, to extend from the interior to the exterior of the case 1100. The one or more orifices 1108 and 1110 are shown illustratively in
The case 1100 may enable long term (greater than one year) implantation of the circuit 300, 600, 700, 800 within patients. In some embodiments, case 1100 comprises of lithium, ceramic-based materials and/or medical grade alloys of stainless steel. Titanium is used in one preferred embodiment, and illustrative case 1100 may comprise pure medical grade titanium. The case 1100 may be one of the variety of sizes and shapes of cases commercially provided by Medtronic, Inc., of Minneapolis, Minn. or Boston Scientific Corp. of Boston, Mass. Alternatively, the case 1100 may comprise a titanium tube having an outer diameter and an inner diameter, as available in various sizes from LN Industries S.A., Grandeson, Switzerland. The individual portions 1102 and 1104 of the case 1100 may be laser machined and welded together to form a hermetically sealed barrier to fluids after the circuit 300, 600, 700, 800 is placed inside during assembly. For example, Laserage Technology of Wakegan, Ill. provides laser welding of titanium cases.
The overall size of the case 1100 may be on the order of about 4 cm×3 cm×2 cm with a wall thickness of about 0.6 mm to about 7 cm×6 cm×3 cm with a wall thickness of about 0.7 mm. The orifices 1108 and 1110 may be pre-machined holes, and may be sealed by conventional glass and/or titanium annealing, elastomer or polycarbonate seals to act as fluid barriers after assembly. In another embodiment the electrodes may be soldered to externalized micro-dot gold or titanium connectors, and the joints protected with medical grade elastomer or sealant. Welding of the case 1100 may be accomplished with YAG lasers. Serial numbers and other identifiers can also be etched by laser or other engraving techniques onto the surface of the case 1100.
While this invention has been described as having a preferred design, the present invention can be further modified within the scope and spirit of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. For example, the methods disclosed herein and in the appended claims represent one possible sequence of performing the steps thereof. A practitioner of the present invention may determine in a particular implementation of the present invention that multiple steps of one or more of the disclosed methods may be combinable, or that a different sequence of steps may be employed to accomplish the same results. Each such implementation falls within the scope of the present invention as disclosed herein and in the appended claims. Furthermore, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.
This application claims priority to U.S. Provisional Application Ser. No. 60/662,495 entitled DEVICES FOR TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES, by Richard B. Borgens and John M Cirillo filed Mar. 16, 2005; U.S. Provisional Application Ser. No. 60/719,915 entitled RECHARGEABLE SYSTEM FOR TREATMENT OF NEURAL INJURIES, by Richard B. Borgens, Pedro Irazoqui and John M Cirillo filed Sep. 23, 2005; U.S. Provisional Application Ser. No. 60/719,911 entitled ENCASED SYSTEM FOR TREATMENT OF NEURAL INJURIES, by Richard B. Borgens, Pedro Irazoqui and John M Cirillo filed Sep. 23, 2005; and, U.S. Provisional Application Ser. No. 60/719,818 entitled SYSTEM FOR TREATMENT OF MOTOR NEURON INJURIES, by Richard B. Borgens, Pedro Irazoqui and John M Cirillo, filed Sep. 23, 2005.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2006/009383 | 3/16/2006 | WO | 00 | 11/1/2007 |
Number | Date | Country | |
---|---|---|---|
60662495 | Mar 2005 | US | |
60719915 | Sep 2005 | US | |
60719911 | Sep 2005 | US | |
60719818 | Sep 2005 | US |